247 related articles for article (PubMed ID: 15778053)
1. Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method.
Takeuchi H; Nagira S; Yamamoto H; Kawashima Y
Int J Pharm; 2005 Apr; 293(1-2):155-64. PubMed ID: 15778053
[TBL] [Abstract][Full Text] [Related]
2. Solid dispersion of spironolactone with porous silica prepared by the solvent method.
Uchino T; Yasuno N; Yanagihara Y; Suzuki H
Pharmazie; 2007 Aug; 62(8):599-603. PubMed ID: 17867555
[TBL] [Abstract][Full Text] [Related]
3. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
4. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
5. Increasing the dissolution rate of a low-solubility drug through a crystalline-amorphous transition: a case study with indomethacin [correction of indomethicin].
Pan X; Julian T; Augsburger L
Drug Dev Ind Pharm; 2008 Feb; 34(2):221-31. PubMed ID: 18302042
[TBL] [Abstract][Full Text] [Related]
6. Stability of amorphous drug, 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2H-pyridazin-3-one, in silica mesopores and measurement of its molecular mobility by solid-state (13)C NMR spectroscopy.
Miura H; Kanebako M; Shirai H; Nakao H; Inagi T; Terada K
Int J Pharm; 2011 May; 410(1-2):61-7. PubMed ID: 21421036
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of surface crystallisation of amorphous indomethacin particles in physical drug-polymer mixtures.
Priemel PA; Laitinen R; Barthold S; Grohganz H; Lehto VP; Rades T; Strachan CJ
Int J Pharm; 2013 Nov; 456(2):301-6. PubMed ID: 24012867
[TBL] [Abstract][Full Text] [Related]
8. Tabletting of solid dispersion particles consisting of indomethacin and porous silica particles.
Takeuchi H; Nagira S; Tanimura S; Yamamoto H; Kawashima Y
Chem Pharm Bull (Tokyo); 2005 May; 53(5):487-91. PubMed ID: 15863917
[TBL] [Abstract][Full Text] [Related]
9. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
[TBL] [Abstract][Full Text] [Related]
10. Influence of particle design on oral absorption of poorly water-soluble drug in a silica particle-supercritical fluid system.
Miura H; Kanebako M; Shirai H; Nakao H; Inagi T; Terada K
Chem Pharm Bull (Tokyo); 2011; 59(6):686-91. PubMed ID: 21628901
[TBL] [Abstract][Full Text] [Related]
11. Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs.
Wang F; Hui H; Barnes TJ; Barnett C; Prestidge CA
Mol Pharm; 2010 Feb; 7(1):227-36. PubMed ID: 19874003
[TBL] [Abstract][Full Text] [Related]
12. Improvement in the water solubility of drugs with a solid dispersion system by spray drying and hot-melt extrusion with using the amphiphilic polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer and d-mannitol.
Ogawa N; Hiramatsu T; Suzuki R; Okamoto R; Shibagaki K; Fujita K; Takahashi C; Kawashima Y; Yamamoto H
Eur J Pharm Sci; 2018 Jan; 111():205-214. PubMed ID: 28893625
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of solid dispersions of nitrendipine prepared with fine silica particles using the melt-mixing method.
Wang L; Cui FD; Sunada H
Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):37-43. PubMed ID: 16394546
[TBL] [Abstract][Full Text] [Related]
15. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size.
Shen SC; Ng WK; Chia L; Hu J; Tan RB
Int J Pharm; 2011 May; 410(1-2):188-95. PubMed ID: 21419202
[TBL] [Abstract][Full Text] [Related]
16. Carvedilol dissolution improvement by preparation of solid dispersions with porous silica.
Planinšek O; Kovačič B; Vrečer F
Int J Pharm; 2011 Mar; 406(1-2):41-8. PubMed ID: 21219991
[TBL] [Abstract][Full Text] [Related]
17. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J
Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816
[TBL] [Abstract][Full Text] [Related]
18. Spray-dried microparticles containing polymeric nanocapsules: formulation aspects, liquid phase interactions and particles characteristics.
Tewa-Tagne P; Briançon S; Fessi H
Int J Pharm; 2006 Nov; 325(1-2):63-74. PubMed ID: 16872767
[TBL] [Abstract][Full Text] [Related]
19. Effect of wet milling process on the solid state of indomethacin and simvastatin.
Sharma P; Denny WA; Garg S
Int J Pharm; 2009 Oct; 380(1-2):40-8. PubMed ID: 19576976
[TBL] [Abstract][Full Text] [Related]
20. Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.
Li Y; Rantanen J; Yang M; Bohr A
Eur J Pharm Sci; 2019 Mar; 129():1-9. PubMed ID: 30553059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
